Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1971 1
1972 1
1973 1
1974 4
1976 4
1977 6
1978 5
1979 2
1980 4
1981 6
1982 2
1983 8
1984 9
1985 10
1986 8
1987 9
1988 15
1989 11
1990 9
1991 11
1992 7
1993 9
1994 7
1995 6
1996 7
1997 7
1998 11
1999 12
2000 7
2001 4
2002 5
2003 2
2004 3
2005 8
2006 7
2007 8
2008 8
2009 11
2010 13
2011 14
2012 8
2013 9
2014 2
2015 14
2016 3
2017 5
2018 4
2019 3
2020 2
2021 3
2022 2
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive mutational profiling of core binding factor acute myeloid leukemia.
Duployez N, Marceau-Renaut A, Boissel N, Petit A, Bucci M, Geffroy S, Lapillonne H, Renneville A, Ragu C, Figeac M, Celli-Lebras K, Lacombe C, Micol JB, Abdel-Wahab O, Cornillet P, Ifrah N, Dombret H, Leverger G, Jourdan E, Preudhomme C. Duployez N, et al. Among authors: lacombe c. Blood. 2016 May 19;127(20):2451-9. doi: 10.1182/blood-2015-12-688705. Epub 2016 Mar 15. Blood. 2016. PMID: 26980726 Free PMC article.
Al amyloidosis.
Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, Quellard N, Lacombe C, Goujon JM, Lavergne D, Abraham J, Touchard G, Fermand JP, Jaccard A; Centre national de référence pour l’amylose AL et les autres maladies par dépôts d’immunoglobulines monoclonales. Desport E, et al. Among authors: lacombe c. Orphanet J Rare Dis. 2012 Aug 21;7:54. doi: 10.1186/1750-1172-7-54. Orphanet J Rare Dis. 2012. PMID: 22909024 Free PMC article. Review.
Resistance to erythropoietin.
Lacombe C. Lacombe C. N Engl J Med. 1996 Mar 7;334(10):660-2. doi: 10.1056/NEJM199603073341012. N Engl J Med. 1996. PMID: 8592534 No abstract available.
Biology of erythropoietin.
Lacombe C, Mayeux P. Lacombe C, et al. Haematologica. 1998 Aug;83(8):724-32. Haematologica. 1998. PMID: 9793257 Review.
Erythropoiesis and transferrin receptors.
Moura IC, Hermine O, Lacombe C, Mayeux P. Moura IC, et al. Among authors: lacombe c. Curr Opin Hematol. 2015 May;22(3):193-8. doi: 10.1097/MOH.0000000000000133. Curr Opin Hematol. 2015. PMID: 25767952 Review.
The molecular biology of erythropoietin.
Lacombe C, Mayeux P. Lacombe C, et al. Nephrol Dial Transplant. 1999;14 Suppl 2:22-8. doi: 10.1093/ndt/14.suppl_2.22. Nephrol Dial Transplant. 1999. PMID: 10334664 Review.
Selective IgG1 deficiency.
Lacombe C, Aucouturier P, Preud'homme JL. Lacombe C, et al. Clin Immunol Immunopathol. 1997 Aug;84(2):194-201. doi: 10.1006/clin.1997.4386. Clin Immunol Immunopathol. 1997. PMID: 9245552
[Erythropoietin].
Casadevall N, Lacombe C, Varet B. Casadevall N, et al. Among authors: lacombe c. Rev Prat. 1988 Jun 23;38(19):1290-4. Rev Prat. 1988. PMID: 2845565 Review. French. No abstract available.
delta-hemolysin, an update on a membrane-interacting peptide.
Verdon J, Girardin N, Lacombe C, Berjeaud JM, Héchard Y. Verdon J, et al. Among authors: lacombe c. Peptides. 2009 Apr;30(4):817-23. doi: 10.1016/j.peptides.2008.12.017. Epub 2008 Dec 27. Peptides. 2009. PMID: 19150639 Review.
Hyperlipidemic dementia.
Mas JL, Bousser MG, Lacombe C, Agar N. Mas JL, et al. Among authors: lacombe c. Neurology. 1985 Sep;35(9):1385-7. doi: 10.1212/wnl.35.9.1385. Neurology. 1985. PMID: 4022389
331 results